North Canyon Medical Center | |
267 North Canyon Dr, Gooding, Idaho 83330 | |
(208) 934-4433 | |
Name | North Canyon Medical Center |
---|---|
Type | Critical Access Hospital |
Location | 267 North Canyon Dr, Gooding, Idaho |
Ownership | Voluntary non-profit - Private |
Emergency Services | No |
Medicare ID (CCN) | 131302 |
NPI Number | 1295769537 |
Organization Name | GOODING COUNTY HOSPITAL DISTRICT |
Address | 1120 Montana St, Gooding, ID 83330 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 208-934-4433 |
News Archive
The American Medical Group Association (AMGA), a professional association representing multispecialty medical groups and other organized systems of care, today released its comments on proposed regulations for Medicare's Shared Savings Program, popularly known as Accountable Care Organizations (ACOs).
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
› Verified 8 days ago
NPI Number | 1609046671 |
Organization Name | NORTH CANYON MEDICAL CENTER INC. |
Doing Business As | NORTH CANYON MEDICAL CENTER |
Address | 267 North Canyon Drive, Gooding, ID 83330 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 208-934-4433 |
News Archive
The American Medical Group Association (AMGA), a professional association representing multispecialty medical groups and other organized systems of care, today released its comments on proposed regulations for Medicare's Shared Savings Program, popularly known as Accountable Care Organizations (ACOs).
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
› Verified 8 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
The American Medical Group Association (AMGA), a professional association representing multispecialty medical groups and other organized systems of care, today released its comments on proposed regulations for Medicare's Shared Savings Program, popularly known as Accountable Care Organizations (ACOs).
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease. The data provide hypotheses for further investigation of this agent in anemia management in this patient population.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
› Verified 8 days ago
North Canyon Medical Center Critical Access Hospital Location: 267 North Canyon Dr, Gooding, Idaho 83330 Phone: (208) 934-4433 |